News Resources
Latest News
- Bloomington's Med-Tech Industry Featured in Fast Company Magazine ..more
- Fund to Focus on Early Stage Life Sciences Ventures ..more
- Indiana University biologist awarded over $2.3 million from the National Institutes of Health ..more
- BioCrossroads Highlights Indiana's Exceptional Life Sciences Sector With Interactive 2011 Report... more
- Medical Devices Industry Identified as One of Indiana's Most Valuable Economic Assets... more
- Biocrossroads Report Shows Life Sciences Creates $44 Billion Impact Statewide | June 2011 ...more
- BioCrossroads Establishes New Educational Series to Focus on Life Sciences Topics | January 2011 ...more
- Indiana Life Sciences Collaboration Conference: Update on Regulatory Compliance at Barnes & Thornburg LLP to be held February 25 | January 2011 ...more
News
Bloomington's Med-Tech Industry Featured in Fast Company Magazine
Bloomington's life sciecnes and medical device clusters were recently highilghted in an article in Fast Company magazine. The article, "Bloomington's MEdTech Industry Is A Lifesaver," includes details on some of the most developed technologies in the nation.
To read the article, visit http://www.fastcompany.com/1836156/bloomingtons-med-tech-industry-is-a-lifesaver.
Fund to Focus on Early Stage Life Sciences Ventures
INDIANAPOLIS, April 30, 2012 -- BioCrossroads announced today the formation of the Indiana Seed Fund II (the Fund), an early-stage capital fund focused on identifying, creating and developing the next generation of Indiana-based life sciences companies.
To view the new release, visit http://www.insideindianabusiness.com/newsitem.asp?id=53459.
IU Researcher Receives Millions
BLOOMINGTON, Ind. - An Indiana University biologist has been awarded over $2.3 million from the National Institutes of Health to genetically modify variants of the human pathogen chlamydia in hopes of finding a vaccine for the most commonly reported bacterial infectious disease in the United States.
To view the entire news release, visit http://www.insideindianabusiness.com/newsitem.asp?ID=52959#middle.
BioCrossroads Highlights Indiana's Exceptional Life Sciences Sector With Interactive 2011 Report
In a report by BioCrossroads, the Indiana Life Sciences sector is detailed in industry employment & wages, entrepreneurial activity, research university activity, and more.
To view the report, visit http://www.biocrossroads.com/Newsroom/IN-Life-Sciences-Sector/Exceptional-Results.aspx.
Medical Devices Industry Identified as One of Indiana's Most Valuable Economic Assets
In a report released by BioCrossroads, the medical devices industry is identified as one of Indiana’s most valuable economic assets employing over 20,000 people, and generating more than $10 billion of annual economic output. The first of its kind report, From Hearts to Hips: Indiana’s Leadership in Medical Devices was written by BioCrossroads and FaegreBD Consulting to provide an overview of the sector and identify challenges on the horizon.
To view the report, visit http://www.biocrossroads.com/Documents/Reports/2012-Indiana-Medical-Devices-Report.aspx.
________________________________________________________________________________________________________________________________
Biocrossroads Report Shows Life Sciences Creates $44 Billion Impact Statewide
The state's life sciences initiative is providing the first in-depth look at the sector. BioCrossroads Chief Executive Officer David Johnson says the industry has a $44 billion impact on Indiana's economy. The report, authored by economic development consultant Walter Plosila, also shows life sciences jobs in the state increased 21 percent between 2002 and 2009. The study is a follow-up on an action plan put together by the initiative in 2002.BioCrossroads is launching a new conference series. Frameworx will focus on timely educational topics relevant to Indiana's life sciences sector. The first event, set for February 8, will feature Lilly Research Laboratories President Dr. Jan Lundberg.
For complete story, visit www.biocrossroads.com.
Indiana Life Sciences Collaboration Conference: Update on Regulatory Compliance at Barnes & Thornburg LLP to be held February 25
Sponsors for the upcoming conference include Barnes & Thornburg LLP, Mead Johnson Nutrition, Anson Group and Beckman Coulter, Inc. They have put together a diverse and very knowledgeable lineup of speakers and panel members experienced in various aspects of the regulatory environment. The keynote speakers are Peter Pitts, President & Co-Founder, Center for Medicine in the Public Interest, Former Associate Commissioner for External Relations, U.S. Food and Drug Administration and Steve Usdin, Senior Editor of BioCentury Publications who has spent the past 15 years covering political and policy issues affecting the life sciences sector in Washington. In addition, there will be a panel on New Product Reviews and Approvals and a panel on Current Business Operations
Overview
The new administration, leadership and legislation all contribute to the recent changes in how the FDA performs its role. At the same time, manufacturers of pharmaceutical products, nutritionals, medical devices, diagnostic equipment and other medical technologies are constantly looking for new ways to distribute, market and sell their products. Many would say that the effects of this combination are putting businesses under more regulatory scrutiny, subjecting companies to more liability and delaying the availability of new products and therapies to healthcare providers and ultimately, the public. This program will bring experts from industry and the regulatory environment together to discuss whether this is indeed the case and review strategies for the future.
The registration fee for each conference is $90.
To register online, go to:
http://www.kelley.iu.edu/CBLS/conferences/registration/page16551.html
To register by mail, please print and complete registration form available
online at the above link and send it with your check (made payable to
Indiana University with a note in the memo line Conf #712-10) to:
Indiana University
IU Conferences
P.O. Box 6212
Indianapolis, IN 46206-6212
Indiana Health Industry Forum to Give Presentation on Social Media for the Life Sciences
The IHIF is offering a program, "Social Media for the Life Sciences" on November 8 from 2pm to 7pm. The event will feature a keynote presentation by Chris Franck, Principal Deloitte Consulting, LLP and a discussion panel moderated by Kristin Eilenberg.
For more information or to register for the event, visit http://www.ihif.org/calendar/view/210.
Indiana Health Industry Forum to Give Presentation on 510 (k) Reform
IHIF Press Release, October 2010
INDIANAPOLIS, Ind. -- While much has been debated in the 510(k) realm, we have yet to see true statistical data - until now. Ralph Hall, counsel for Baker & Daniels, recently completed the first major study examining the 510(k) system. This presentation, which is sponsored by IHIF, IMDMC and Baker & Daniels LLP, will provide a detailed look into his research and the resulting potential implications for the 510(k) system.
The Institute of Medicine (IOM) is in the midst of an 18-month assessment of the 510(k) system and whether it provides adequate product safety. Hall's work will be presented to the IOM and those Congressional offices interested in possible changes to the system. Hall's study will provide the aforementioned policy makers with the critical data they need to make 510(k) guidance decisions.
The event is scheduled for Thursday, November 11, 2010 from 8:00 am to 10:00 am at the Indiana University Emerging Technologies Center(IUETC), 351 W. 10th Street, Indianapolis, IN 46202
Tech Park Evolving in Bloomington
Inside INdiana Business, August 23, 2010
BLOOMINGTON, Ind. -- A unique technology corridor is taking shape at Indiana University Bloomington. The Cyberinfrastructure Building is currently under construction and designed to be a social hub of the tech park.
The facility is located between the IU Innovation Center and the IU Data Center. IU Vice President for Engagement Bill Stephan says the incubator signals the school is dedicated to foster technology and economic development.
http://www.insideindianabusiness.com/newsitem.asp?ID=43285
2010-11 Indiana Life Sciences Collaboration Conference series begins with focus on health care reform
IU Press Release, August 16, 2010BLOOMINGTON, Ind. -- The successful Indiana Life Sciences Collaboration Conference Series will begin its fifth year in Indianapolis with a look at the future impact of the Health Reform Bill enacted in March.
Everyone involved with the U.S. health care system and its major stakeholders, including patients, is gauging the sweeping impact of the legislation. The conference will feature presentations by representatives from policymakers and Indiana's life science industry.
Nick Littlefield, former chief of staff to health care reform's champion, the late Sen. Edward M. Kennedy, is among the participants at the conference, which will take place 8 a.m. to 3:30 p.m., Sept. 17, at the Indiana University/Clarian Education and Resource Center, Fairbanks Hall, 340 W. 10th Street, in Indianapolis. The conference series is presented by the Indiana University Kelley School of Business and its Center for the Business of Life Sciences, BioCrossroads and Duke Energy.
"As government works to implement the provisions of the health care reform legislation, ramifications of the bill are becoming more understood, and more questions are being raised as to the appeal and viability of a number of its provisions," said George Telthorst, director of the Center for the Business of Life Sciences in IU's Kelley School of Business. "This conference will update attendees on the latest that is now understood about the bill, how things are likely to shake out if things remain unchanged, and possible modifications in the future.
"We are thrilled to have someone who was intimately involved in the discussions and campaign for approval of this legislation that was so vitally important to Sen. Kennedy and his legacy," Telthorst added. "Mr. Littlefield is in a unique position to talk about the balancing of all the interests that were required to secure the bill's passage."
The Sept. 17 event is the first in a series of four conferences. The cost is $90 or $320 for the entire series. Other events in the series will take place Nov. 19 at Cook headquarters in Bloomington, and Feb. 25 in Indianapolis at Barnes & Thornburg LLP, and May 13 also in Indianapolis at the IU School of Medicine's Walther Hall Auditorium. Registration and additional information is available online at http://www.kelley.iu.edu/CBLS/conferences/registration/page16551.html or by contacting Kelli Conder at the Kelley School at 812-856-0915 or kconder@indiana.edu.
Following registration and networking from 8 to 9 a.m., Robert Brown, senior vice president and chief marketing officer at Eli Lilly and Co., will offer introductory comments.
Brown will be followed by the first panel, "The Present from a Manufacturer's Perspective." Robert McDonald, president of Aledo Consulting Inc., will moderate. Panelists will be Jay Bonditt, vice president, federal government affairs at Eli Lilly and Co.; Christopher Cerone, vice president, government affairs at Zimmer; and Timothy Franson, senior vice president of B&D Consulting.
A second morning panel discussion, "The Present from a Provider's and Payer's Perspective," will be moderated by Patrick Cross, a partner in Baker and Daniels LLP and its health care and life sciences practice leader. Panelists will be Robert Hillman, president and general manager, Anthem Blue Cross and Blue Shield of Indiana; Ronald Stiver, senior vice president for engagement and external affairs at Clarian Health; and Michael Rinebold, director of government relations at the Indiana State Medical Association.
Neil Picket, director of health policy research at Clarian Health, will introduce Littlefield, the lunch speaker. Littlefield, who today is a partner in the Boston and Washington law firm Foley Hoag LLP, will speak on the topic, "How We Got Here and Where It Could Go."
The final panel discussion will follow lunch, and is simply titled, "The Future." Vincent Ventimiglia, senior vice president of B&D Consulting, will moderate. Panelists will be Mike Ripley, vice president for health care policy at the Indiana Chamber of Commerce; Kenneth Weixel, U.S. managing partner at Deloitte & Touche LLP and senior advisor at the Deloitte Center for Health Solutions; and Nancy Davenport-Ennis, chief executive officer and president of the National Patient Advocate Foundation.
At about 3 p.m., Telthorst will wrap up the day's discussions.
Other financial sponsors are AIT Laboratories; Aledo Consulting; Anson Group; Baker & Daniels LLP; Barnes & Thornburg LLP; Beckman Coulter, Inc.; BSA Life Structures; Clarian Health Ventures; Cook Medical; Commissioning Agents Inc.; Eli Lilly and Co.; Indiana Health Information Exchange; Ice Miller LLP; the Indiana Clinical and Translational Sciences Institute; the IU School of Medicine; Mead Johnson Nutrition; Meyer Najem; NoMoreClipboard.com' Purdue University; Symmetry Medical; Taft Stettinius and Zimmer.
Brochure sponsors are Cabello Associates, Inc.; and Miles Printing on Plastics. Marketing sponsors are BioConvergence LLC; Bloomington Life Sciences Partnership; Covidien Imaging Solutions; Deloitte Center for Health Solutions; Indiana Healthcare Businesswoman's Association; Indiana Health Industry Forum; IU College of Arts and Sciences; IU Research and Technology Corp.; the Kelley School's Evening MBA Program; the Kelley School of Business Alumni Association; IU Maurer School of Law; IU Office for the Vice President for Engagement; OrthoWorx; and the University of Notre Dame.
More information about the Center for the Business of Life Sciences is available online at http://kelley.iu.edu/cbls/.
IHIF Partners with TGV LLC on International Programs
IHIF Press Release, August 10, 2010
The Indiana Health Industry Forum announced that it has signed a partnership agreement with TGV LLC, the organizer and producer of the international BioPartnering events. With this partnership, IHIF members will receive a 15% discount on the registration fee for the series of events. To obtain the promo code for the IHIF member discount*, please contact IHIF at 317-278-9970 or e-mail info@ihif.org. Information on two of the upcoming events is included. Additional information may be found on the IHIF website and calendar.
Conference Name: BioPartnering Europe™
Dates: 10-12 October 2010
Location: London, United Kingdom
Venue: QEII Conference Centre
Description: BioPartnering Europe™ (BPE) Leading European life science partnering for 18 years.
BPE offers excellent partnering opportunities for the best and brightest in the life science industry. Three days of networking in 1 location to meet with decision-makers from leading biotechnology, pharmaceutical, and investment companies from around the world for face-to-face partnering meetings, presentations, expert panels, and exhibitions. Register for BPE and connect your company with The Global Life Science Network™.
For more information and to register, visit: http://www.techvision.com/bpe/
Conference Name: BioPartnering Latin America™
Dates: 19-21 September 2010
Location: Rio de Janeiro, Brazil
Venue: Sofitel Rio de Janeiro Copacabana
Description: BioPartnering Latin America™ (BPL) will bring together professionals from all over the world, including the Latin American region from Mexico to Chile, Brazil, and Argentina. The focus of BPL will be life science, including human, animal and plant health and technology; highlighting the fast growing sector of innovative Latin American companies which will present significant partnering opportunities.
BPL will offer three days of networking opportunities filled with pre-scheduled face-to-face partnering meetings, expert panels and workshops. BPL is presenting the opportunity to explore the emerging market of Latin America. Register for BPL and connect your company with The Global Life Science Network™.
For more information and to register, please visit: http://www.techvision.com/bpl/
*Some restrictions apply: discount applies to general admission fees only and cannot be applied to presenter fees, cannot be used in conjunction with any other discounts, and cannot be applied retroactively. Any legal firms or lawyers wishing to attend BPE must sponsor the event. If you know a firm or company interested in sponsorship, please contact sponsorsales@techvision.com.
IU, Cook Launch Invention Website i2iconnect.org
July 13, 2010BLOOMINGTON, Ind. -- For medical researchers and inventors, discovering new innovative technologies is only a first step. To save lives and improve human health, these treatments and devices must make it from the lab to the marketplace -- a process that can be time consuming and filled with roadblocks.
In an effort to streamline this process, Indiana University's Pervasive Technology Institute (PTI), the Indiana Clinical and Translational Sciences Institute (CTSI), and Cook Medical have worked together to create i2iconnect.org, a unique online service that matches inventors and technology transfer professionals with companies looking to develop their inventions into commercially viable products.
"Health care research and products have become highly specialized and inventors and technology transfer organizations are struggling to find the right licensing partner," said Bill Barnett, senior manager of life sciences for PTI. "i2iconnect gives them a place where they can find current, accurate information on the innovations companies are seeking."
i2iconnect makes matches through an easy-to-use, free web interface that accesses a database of medical companies. Users look for potential partners by searching specific keywords or disease categories. Technology transfer offices find that the service helps broaden the search for innovation partners, speeding the technology transfer process.
"i2iconnect addresses a critical and often challenging step in the translational medicine life cycle," said Indiana CTSI director Anantha Shekhar. "In order for medical and scientific research to have real impact, new technologies must reach the market and the patients."
With more than 5,500 medical device, biotechnology, and pharmaceutical manufacturers in North America alone, bringing technology from the lab to the bedside can be highly complex. Medical schools and researchers must find a manufacturing partner that suits their research objectives, and manufacturers must match their research interests with projects that are relevant to their strategic clinical focus from the more than 125 medical schools in North America. The i2iconnect.org system will potentially carve months from the search process by helping companies and researchers find the right partner quickly, reducing the amount of time and energy both sides spend corresponding with potential partners who do not have compatible interests.
"The i2iconnect system is going to be a significant time-saver for both manufacturers and university researchers," said Thomas Cherry, product development manager of Cook Medical's Critical Care division. "The greatest benefit of such a system -- and a missing piece to the puzzle -- is that it will effectively link researchers with the appropriate industry personnel contact at a much faster pace than was previously possible. The length of time to advance new innovative technologies to the patients has just been significantly shortened."
i2iconnect is supported in part by an award from the National Institutes of Health American Recovery and Reinvestment Act to the Indiana Clinical and Translational Sciences Institute (CTSI) through the National Center for Research Resources. The Indiana CTSI focuses on translational science, a new model of research that works to convert medical discoveries from the laboratory into products and treatments for improving human health.
"Tools such as i2iconnect, illustrate how Recovery Act funds have been leveraged to enhance the ability of researchers to find and develop partnerships with industries that can turn their inventions into drugs and devices that add value to patient care," said Barbara Alving, M.D., director, National Center for Research Resources, National Institutes of Health.
For more information or to use i2iconnect, visit http://i2iconnect.org/.
About Pervasive Technology Institute at Indiana University
Supported by a $15-million grant from the Lilly Endowment, Inc. Pervasive Technology Institute (PTI) is a leading-edge technology organization dedicated to the development and delivery of innovative information technology to advance research, education, industry and society. For more information, visit http://pti.iu.edu/.
About Cook Medical
Founded in 1963, Cook Medical pioneered many of the medical devices now commonly used to perform minimally invasive medical procedures throughout the body. Today, the company integrates medical devices, drugs and biologics to enhance patient safety and improve clinical outcomes. Since its inception, Cook has operated as a family-held private corporation. For more information, visit http://www.cookmedical.com/. Follow Cook Medical on Twitter at http://www.twitter.com/CookMedicalPR.
Source: Cook Medical, Indiana University
Centerstone Research Institute Recognized as a 2010 Best Practices Awards Winner by The Data Warehousing Institute
1105 Media Press Release, July 8, 2010National award recognizes organization’s innovative data warehouse
Bloomington, Ind. and Nashville, TN. – Centerstone Research Institute (CRI), a unique not for-profit organization dedicated to improving mental healthcare through research and information technology, has been recognized as a 2010 Best Practices Award Winner by The Data Warehousing Institute (TDWI). Honored for its innovative data warehouse, CRI is the first behavioral health organization ever to be recognized by TDWI.
“We are thrilled to receive the TDWI Best Practices Award,” said Dennis Morrison, PhD, Chief Executive Officer of CRI. “This is a significant validation of CRI’s data warehouse, which was launched only two years ago. This data warehouse provides critical operational and management tools that can improve the quality of patient care and prevent clinician errors, while saving time and resources.”
TDWI's Best Practices Awards program honors companies that have demonstrated excellence in developing, deploying and maintaining business intelligence (BI) and data warehousing (DW) applications. CRI was selected as one of two winners in the Government and Non-Profit category along with the Transportation and Security Administration (TSA) and Solution Sponsor: MicroStrategy.
CRI’s data warehouse is a collection of anonymous data that is designed to help implement research-based practices at mental health centers. An electronic clearing house, it empowers end users with actionable information to improve their business management and clinical practices. End users can explore vital information related to service quality, financial viability, and client outcomes, as well as predictive models that can better inform decisions that would most likely result in positive clinical outcomes. CRI’s system has helped produce a 30 percent increase in annual revenues in one year with staff productivity also rising 30 percent.
“Business intelligence is a key tool for any organization’s success,” said Richard Zbylut, president of TDWI. “Year after year our awards showcase forward thinking organizations for developing and implementing world-class solutions. We are pleased to recognize this year’s Best Practices Award winners on their innovative implementations. We hope that our program 2 and the winning solutions serve as a powerful educational tool for technical and business professionals as they implement BI and DW strategies.”
Best Practices Award nominations were evaluated on business impact, maturity, innovation and relevance. Companies and sponsoring solution providers from diverse industries submitted entries that were judged in a variety of categories. Award winners were chosen by a panel of independent judges who have expertise in business intelligence and data warehousing.
Best Practices Awards winners will be honored at the TDWI World Conference, which will take place August 15-20, 2010, at the Manchester Grand Hyatt San Diego Hotel. Previous Best Practices winners include organizations such as Boeing, Lawrence Livermore National Laboratory, Memorial Sloan-Kettering Cancer Center, eBay, IBM, Union Pacific, Blue Cross Blue Shield of North Carolina, National Basketball Association and Louisiana Pacific Corporation.
About Centerstone Research Institute
Centerstone Research Institute (CRI) is a unique not-for-profit organization dedicated to improving mental healthcare through research, information technology and clinical informatics. CRI conducts service and clinical studies and partners with leading research institutions to advance knowledge of mental health and addiction disorders and discover innovative treatments. The organization maintains an Institutional Review Board and manages the Knowledge Network, a technology-based, partner-driven alliance to facilitate the translation of research to practice. CRI also offers Behavioral Pathway Systems, a best practices benchmarking service. CRI is a recipient of the National Council for Community Behavioral Healthcare’s Innovation Award. For more information about CRI, please visit
www.centerstoneresearch.org.
About TDWI
The Data Warehousing Institute™ (TDWI), a division of 1105 Media, Inc., is the premier provider of in-depth, high-quality education and research in the business intelligence and data warehousing industry. TDWI is dedicated to educating business and information technology professionals about the strategies, techniques, and tools required to successfully design, build, and maintain business intelligence and data warehousing solutions. It also fosters the advancement of business intelligence and data warehousing research and contributes to knowledge transfer and professional development of its Members. TDWI sponsors and promotes a worldwide Membership program, quarterly educational conferences, regional educational seminars, role-based training, onsite courses, certification, solution provider partnerships, an awards program for best practices, resourceful publications, an in-depth research program, and a comprehensive Web site (www.tdwi.org).
About 1105 Media
1105 Media, Inc., is a leading provider of integrated information and media in targeted business-to-business markets, including specialized sectors of the information technology community; industrial health, safety, and compliance; security; environmental protection; and home healthcare. 1105's offerings span print and online magazines, journals, and newsletters; seminars, conferences, and trade shows; training courseware; and Web-based services. 1105 Media is based in Chatsworth, CA, with offices throughout the United States.
48D Qualifying Therapeutic Discovery Project Credit $1 Billion in Tax Credits and Grants for Life Sciences Companies
BEDC Press Release, June 10, 2010On March 23, 2010, President Obama signed the Patient Protection and Affordable Care Act (also known as the Health Care Reform Bill) which included the creation of Internal Revenue Code section 48D, providing life sciences companies the opportunity to obtain a tax credit or cash grant equal to 50 percent of the "qualified investment" in a "Qualifying Therapeutic Discovery Project."
On May 21, 2010, the United States Department of Treasury ("Treasury") issued Notice 2010-45 which provided many of the pertinent details about the §48D program.
The following summary is meant to provide a concise overview of the §48D program. Please contact Krieg DeVault to discuss the program in detail, including whether you are eligible for the tax credit and/or grant.
WHO IS ELIGIBLE?
To be eligible, a company must (i) employ not more than 250 employees in all its businesses (including commonly controlled companies) at the time it submits an application and (ii) not be one of the following types of organization:
(a) Section 501(c) organizations exempt from tax under section 501(a);
(b) Federal, state, and local government agencies; and
(c) Any partnership or other pass-through entity which has, as a holder of an equity or profits interest, a person described in the above two categories.
HOW IS THE AMOUNT OF THE CREDIT/GRANT DETERMINED?
The credit/grant equals 50 percent of a taxpayer's "qualified investment," which is the "aggregate amount" of the costs paid or incurred in a taxable year beginning in 2009 or 2010 for expenses "necessary for and directly related to" the conduct of a qualifying therapeutic discovery project.
Because only $1 billion in credits and grants will be provided with respect to taxable years 2009 and 2010, Treasury has imposed two significant limitations on the award amounts: (i) first, no Applicant may receive an award of more than $5 million and (ii) second, each Applicant will receive the SAME award amount as all other applicants (with a caveat that no Applicant will receive an award amount greater than 50% of their qualified investment amount).
WHAT PROJECTS QUALIFY?
To qualify for the credit/grant, the company must have a "qualifying therapeutic discovery project" ("QTDP"), which means a project designed to:
- Treat or prevent diseases or conditions by conducting pre-clinical activities, clinical trials, and clinical studies, or carrying out research protocols, for the purpose of securing approval of a product under section 505(b) of the Federal Food, Drug, and Cosmetic Act or section 351(a) of the Public Health Service Act;
- Diagnose diseases or conditions or to determine molecular factors related to diseases or conditions by developing molecular diagnostics to guide therapeutic decisions; or
- Develop a product, process, or technology to further the delivery or administration of therapeutics.
- Result in new therapies to treat areas of unmet medical need or prevent, detect, or treat chronic or acute diseases and conditions;
- Reduce long-term health care costs in the United States; or
- Significantly advance the goal of curing cancer within 30 years.
- Create and sustain, directly or indirectly, high-quality, high-paying jobs in the United States; and
- Advance United States competitiveness in the fields of life, biological, and medical sciences.
- June 21, 2010 - the date by which Treasury will publish Form 8942 (the "official" application form for the §48D program).
- July 21, 2010 - the deadline by which all applicants must submit their applications for a credit/grant under §48D.
- September 30, 2010 - the date by which Treasury will complete the preliminary review of all timely filed applications.
- October 29, 2010 - the date by which Treasury notify Applicants whether their application was approved or denied.
If you believe you may be eligible for the §48D program, please contact Krieg DeVault as soon as possible so that we can help you to assess your eligibility and assist you to prepare a §48D application.
Krieg DeVault has significant experience working with various tax credit programs and has assisted its clients in receiving over $24 million in §48C tax credits and over $150 million in §45D tax credits.
You can direct your inquiries to Matthew E. Conrad at (317) 238-6326 or mconrad@kdlegal.com or anyone else at Krieg DeVault with whom you work.
Baxter’s BioPharma Solutions Business Wins “Best CMO” in Vaccine Industry Excellence Awards
BEDC Press Release, June 10, 2010BLOOMINGTON, Ind. -- BioPharma Solutions (BPS), Baxter’s contract manufacturing business, was named "Best Contract Manufacturing Organization" at the third annual Vaccine Industry Excellence (ViE) Awards, announced on April 20, 2010, at the World Vaccine Congress in Washington, D.C. This is the first time Baxter has received this award, which is a testament to the company’s commitment to excellence in contract manufacturing and customer service.
The VIE awards were created to honor and recognize individuals and companies making significant contributions or accomplishments in the global vaccine industry. Criteria for the “Best CMO” award included the range of services provided in niche and core therapeutic areas; methods of performance improvement or introduction of new services; attention to and quality of relationships with clients; milestones reached and final / ongoing outcomes; and building and maintaining existing and long term partnerships.
For additional information on the awards program, please visit http://www.terrapinn.com/2010/vie/.
About BioPharma Solutions
For more than 20 years, BioPharma Solutions – a unit of Baxter’s Medication Delivery business -- has been a leader in pharmaceutical and biotechnology contract manufacturing, offering services for pre-filled syringes, liquid and lyophilized vials and cartridge filling, and specialized capabilities for cytotoxics and biologics manufacturing. With a proven history of innovation, scientific expertise, proprietary technology and global scope, BioPharma Solutions helps pharmaceutical companies around the world connect to the resources they need in every phase of the molecule’s life cycle – from formulation and manufacturing, to packaging and delivery.
HealthLINC to Help Physicians Use Electronic Health Records through New Federal Program
HealthLINC Press Release, March 30, 2010Funding will pave the way for area providers to receive incentive payments for using electronic systems and exchanging health information electronically to improve health care
BLOOMINGTON, Ind. -- March 30, 2010 - U.S. Department of Health and Human Services (HHS) announced that HealthBridge was awarded federal funding to help area physicians transition to electronic health records. The announcement is part of a multi-phased effort by HHS to improve the quality and efficiency of health care by moving the country toward computerized health records.
HealthBridge's tri-state application includes partnerships with several leading health IT organizations throughout the region including HealthLINC, Collaborating Communities Health Information Exchange, Northeast Kentucky Regional Health Information Organization, and the University of Kentucky as well as area universities and community colleges and state government organizations.
"We believe our partnership with HealthBridge will help our region to expand rapidly the use of electronic health records and health information exchange," said Dr. Todd Rowland, Executive Director of HealthLINC, a health information exchange serving central and southern Indiana.
The REC program will offer technical assistance to small physician practices, community health centers and other priority providers. The federal funds do not pay for electronic systems directly but will offer group purchasing arrangements with steep discounts on health IT for physicians.
The announcement by HHS included more than $750 million in grant awards. The assistance at the state and regional level will facilitate health care providers' efforts to adopt and use electronic health records (EHRs) in a meaningful manner that has the potential to improve the quality and efficiency of health care for all Americans. Of the over $750 million investment, $386 million will go to 40 states and qualified State Designated Entities (SDEs) to facilitate health information exchange (HIE) at the state level, while $375 million will go to an initial 32 non-profit organizations to support the development of regional extension centers (RECs) that will aid health professionals to implement and use health information technology.
The REC awards are funded through the American Recovery and Reinvestment Act which established an incentive program for qualified health care professionals and hospitals to demonstrate "meaningful use" of electronic health records and health information exchange. HealthBridge estimates that meaningful use incentive payments could inject more than $200 million into the tri-state region over the next five years.
More information on the Regional Extension Center program is available at www.healthit.hhs.gov. Regional Extension Center support is provided by the Office of the National Coordinator, Department of Health and Human Services under cooperative agreement number 90RC0025/01.
About HealthLINC
HealthLINC is improving care in Southern Indiana and is one of the most advanced and interconnected HIEs in the United States by offering a range of services that enhance results management, medication management, and care coordination across providers. HealthLINC is a non-profit health care organization launched in 2005 and is organized to coordinate health care information by providing a community-wide clinical data and information exchange to the health care community. In 2007 HealthLINC contracted with HealthBridge - one of the nation's largest and nationally recognized HIEs - to provide the technology infrastructure and services on which the HealthLINC HIE operates. For more information about HealthLINC, visit www.healthlinc.org.
About HealthBridge
HealthBridge is one of the nation's largest and most financially successful health information exchange organizations. HealthBridge is a not-for-profit corporation founded in 1997 as a community effort to enhance the ability to share health information electronically in the Greater Cincinnati-Northern Kentucky tri-state area.
Due to HealthBridge and its partners' efforts, the Greater Cincinnati-Northern Kentucky region has become the most advanced region in the country for using electronic health information and connectivity to improve the quality and efficiency of health care. Each month 3 million clinical lab tests, radiology reports, and other clinical messages are transmitted to authorized physicians through HealthBridge's secure electronic network, more than nearly any other community health information exchange in the country. HealthBridge also works collaboratively with several other health information exchanges to assist them with technology and business operations. For more information about HealthBridge, see www.healthbridge.org.
2010 Paid Summer Internship: Project Manager, Bloomington Life Sciences Partnership
Posted April 2, 2010
Description
The Bloomington Economic Development Corporation (BEDC) seeks a qualified Master of Public Affairs (MPA) student for a part-time paid summer internship (approximately 25 hours/week; May – August). The Bloomington Life Sciences Partnership (BLSP) Project Manager will provide assistance to the BEDC President in the implementation of the BEDC’s economic development efforts with a primary focus on the BLSP.
The BLSP Project Manager will work with strategic partners in the life sciences community to foster sector development and growth. Responsibilities include marking and promotion of the BLSP using the partnership’s website, www.bloomingtonlifesciences.com, e-mail newsletters, and various other new media outlets. The Project Manager will also engage in business development activities with area life sciences businesses and organizations. The BLSP Project Manager will also represent the BEDC at various functions and events related to the life sciences industry.
Qualifications
This position is open to continuing Master of Public Affairs (MPA) students at Indiana University’s School of Public and Environmental Affairs. Desirable qualifications include excellent research skills, marketing experience (particularly new media), the ability to communicate clearly in writing and over the phone, and strong interpersonal skills.
An interest in economic development is highly desirable. Experience with information technology systems, web development, and the life sciences industry are also desirable.
Interns at BEDC enjoy flexible schedules and opportunities to engage in professional development activities.
About the BEDC
The BEDC is the lead business retention, development and attraction entity for Bloomington and Monroe County, Indiana; the lead intermediary between local businesses and state and federal economic development assistance programs and the host for the Bloomington Life Sciences Partnership (BLSP) and the Bloomington Technology Partnership.
Through its strategic plan, special projects and extensive relationships and partnerships, the BEDC helps create programs to fill gaps in the local economic development system. Because of this, the BEDC has evolved from an organization originally formed to undertake business attraction to one that focuses on business retention and expansion, new business development and partnerships with Indiana University and Ivy Tech Community College Bloomington.
The BEDC offices are located at 400 W. 7th Street in Bloomington. More information about the BEDC can be found online at www.comparebloomington.us.
The BEDC is an equal opportunity employer.
How to Apply
Submit a resume and cover letter to BEDC President Ron Walker via e-mail at rwalker@comparebloomington.us by 5 pm on Friday, April 9, 2010.
Ivy Tech, ProCure Join Forces with Radiation Simulation Lab
Ivy Tech Community College Press Release, February 12, 2010
BLOOMINGTON, Ind. -- Officials at Ivy Tech Community College and ProCure Treatment Centers, Inc. announced today that Ivy Tech’s radiation therapy degree program simulation lab is complete.
A collaborative agreement affords Ivy Tech radiation therapy students access to state-of-the-art equipment, expert industry training, and classroom resources at the ProCure Training and Development Center (TDC).
Chancellor John Whikehart says that Ivy Tech's Bloomington campus is the only higher education institution in the state of Indiana with an accredited two-year radiation therapy degree program, so it was natural to join with ProCure. “Ivy Tech is thrilled to have signed an affiliation with ProCure, as the TDC is the only facility in the world dedicated to proton therapy training and development,” he said. “We have formed a relationship with ProCure whereby they are donating space and personnel for training, while we have raised private money for equipment donations.”
ProCure built its TDC in Bloomington with space allocated for Ivy Tech’s program. ProCure leased lab space to the college for $1 per year, which creates a savings of approximately $60,000 per year in leased academic space. Using donations, Ivy Tech invested in a fluoroscopic simulator that mimics all of the movements of a linear accelerator (a radiation administration machine).
Ivy Tech students gain experience in using a fluoroscope by “treating” model or phantom patients with the simulator before going to the clinics and treating real patients.
“The simulator, combined with other resources provided by ProCure, gives Ivy Tech students unique opportunities for education and training that do not exist anywhere else,” Whikehart said. “We are fortunate to have these resources exist in one place, making Ivy Tech radiation therapy graduates both nationally and globally competitive.”
Larry G. Swafford, Ph.D., professor and chair of the radiation therapy program at Ivy Tech’s Bloomington campus says it’s difficult for colleges to build labs for radiation therapy degree programs because the equipment is expensive and the labs must be properly shielded to contain the radiation. “This makes building the space more costly than purchasing equipment,” he said. “We could not have a fully functional lab space without the assistance of ProCure.”
Ivy Tech, ProCure and the Midwest Proton Radiotherapy Institute (MPRI) have also collaborated to develop and implement the world’s first proton therapy training certificate program. Certification is available to registered radiation therapists who complete 16 credit hours of didactic, lab and clinical coursework. Students complete the coursework and lab work online and at the TDC, and can complete the clinical portion at MPRI.
“We at ProCure are delighted to have been able to work with the exceptional faculty and staff at Ivy Tech in developing an exceptional training program in proton therapy. Ivy Tech is the first in the nation to offer this type of a certification,” said John Cameron, Ph.D., founder and president of ProCure Treatment Centers, Inc. “There is a significant need for radiation therapists who are skilled in proton therapy, and these graduates will be in demand at centers all over the country. We’re proud that our collaboration with Ivy Tech has resulted in this very fine program.”
Ivy Tech’s radiation therapy degree program has three primary affiliates in Bloomington – Bloomington Hospital, MPRI and ProCure. Students rotate through Bloomington Hospital and MPRI to complete their clinical program requirements.
New IU Innovation Center is Opportunity for Synergy, Success
Indiana University Press Release, November 9, 2009
BLOOMINGTON, Ind. -- Indiana University's Innovation Center, a new $10 million home to university researchers and private start-up companies, was formally dedicated today (Nov. 9) by IU President Michael A. McRobbie.
Citing an array of success stories previously sprung from collaborations between Indiana University and private companies -- the breathalyzer, the lie detector, fluoride toothpaste -- McRobbie idealized on the future for a 40,000-square-foot, state-of-the-art facility being envisioned as a key component of the president's Innovate Indiana initiative.
"This new facility focuses squarely on incubating and translating the most creative research inventions and innovations from IU's faculty, staff and students into new companies and products," he said. "In doing so, it will contribute to the economic development of Bloomington and Indiana. We also expect that this facility will provide a hub for partnerships between the IT and life sciences industry and IU researchers, as well as an outstanding environment for IU students to learn and participate first hand in entrepreneurship."
The Innovation Center, located at 2719 E. 10th St., houses the IU Pervasive Technology Institute (PTI) and will soon provide offices for the Johnson Center for Entrepreneurship and Innovation of the IU Kelley School of Business, the IU School of Informatics, and IU Research and Technology Corp. (IURTC) administrators and staff.
"To answer increasingly complicated questions about the building blocks of life, treatments for disease and the safety of our environment -- to offer just three of thousands of examples -- increasingly requires experts from multiple disciplines," McRobbie said. "And these are not just the scientific disciplines. To translate those answers into goods and services that will help society requires the business acumen so concentrated here at Indiana University."
The path from innovation to implementation has been a fruitful one for IU already this year, he pointed out with references to Angel Learning and Therametric Technologies.
Earlier this year Angel Learning, a company that began at IU's Emerging Technology Center in Indianapolis, was sold for $100 million, making it the largest single technology commercialization transaction in Indiana University history. Another IUETC company, Dr. George Stookey's Therametric Technologies, will grow out of IUETC and move to a larger facility in Noblesville. Stookey, McRobbie pointed out, was involved in some of the earliest fluoride toothpaste research while a graduate student at IU.
And besides an earlier $30 million dollar gift from Lilly Endowment Inc., PTI this year received an additional $15 million award from that endowment. PTI is home to three research centers: the Digital Science Center, the Data to Insight Center and the Center for Applied Cybersecurity Research.
Considered an anchor for the new technology corridor developing along the 10th Street site and planned to expand north along the Ind. 45/46 Bypass, the center will complement a range of life science and technology-based enterprises locating in the area, including the new IU Data Center and the recently-funded Cyberinfrastructure Building that will house many of the University Information Technology Services staff.
The second floor of the Innovation Center will offer specially equipped wet-lab space ideally suited for bio and life science start-up companies.
"Bringing together so many people from across the university creates a heightened environment for innovation in which solutions are right around the corner rather than being across campus, across town or an hour up the highway," McRobbie said. "This is the kind of synergy that led IU faculty and staff to file a record 167 patent applications just last year. This is the kind of synergy that led to 1,839 inventions, 466 patents and 38 startup companies growing out of IU research. And this is the kind of synergy that has led to over $2.1 billion in sponsored research awards for IU researchers over the last five years. That is more than all of Indiana's other public and private research universities combined. And this kind of synergy translates into economic development for the city of Bloomington and the state of Indiana."
Photo Credit: Aaron Bernstein, courtesy of Indiana University
New "Indiana Life Sciences Industry" Report
The Indiana Business Research Center published the a report titled, "The Indiana Life Science Industry," in April 2009.
The life sciences play a key role in the U.S. economy. In 2007, 1.4 million Americans were employed with companies engaged in the research and development, production or distribution of life science products. Even more life scientists are employed at universities and public research laboratories around the country. Furthermore, between 2001 and 2007, average annual employment growth in these industries far outpaced that of total employment (1.2 percent compared to 0.7 percent). Strong growth will almost certainly continue in an effort to meet the ever-expanding demand for health care goods and services. As a case in point, the most recent projections from the Bureau of Labor Statistics predict that U.S. employment in pharmaceutical and medicine manufacturing will grow 24 percent between 2006 and 2016.
The importance of the life sciences extends beyond just employment numbers. This field is characterized by innovation, significant public and private investment, highly skilled talent and excellent wages. For these reasons, building or expanding the life sciences is a top priority of state and local economic development efforts across the country.